MOLECULAR THERANOSTICS, LLC — SBIR/STTR Competitive Profile
Aggregate SBIR/STTR award history for MOLECULAR THERANOSTICS, LLC, built entirely from public federal award records. Free competitive intelligence — no login required.
- 4 awards
- $4,598,100 total on record
- 1 agency
- 2 Phase I · 2 Phase II
Phase mix
- Phase I — 2 awards
- Phase II — 2 awards
Funding agencies
Awards by year
- 2023 — 1 award
- 2022 — 1 award
- 2017 — 1 award
- 2015 — 1 award
Places of performance
Firms like MOLECULAR THERANOSTICS, LLC
See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.
Sign in to see firms like this
The full similar-firms list is free with an account. Sign in or create a free account to compare competitors.
Recent awards
| Award | Agency | Amount | Program | Start |
|---|---|---|---|---|
| 1R43CA281488-01A1 | Department of Health and Human Services | $265,179 | SBIR · Phase I | 2023-08-01 |
| 1R44CA265626-01A1 | Department of Health and Human Services | $2,000,000 | SBIR · Phase II | 2022-09-14 |
| 2R44CA199826-02A1 | Department of Health and Human Services | $2,083,047 | SBIR · Phase II | 2017-08-01 |
| 1R43CA199826-01 | Department of Health and Human Services | $249,874 | SBIR · Phase I | 2015-07-21 |
Frequently asked questions
How many SBIR/STTR awards has MOLECULAR THERANOSTICS, LLC won?
MOLECULAR THERANOSTICS, LLC has won 4 SBIR/STTR awards worth $4,598,100 in the public federal award records SBIR Signal tracks, including 2 Phase I and 2 Phase II award(s).
Which agencies fund MOLECULAR THERANOSTICS, LLC?
MOLECULAR THERANOSTICS, LLC's awards come from 1 agency on record; its top funder is Department of Health and Human Services.
What technology areas does MOLECULAR THERANOSTICS, LLC work in?
Based on its award history, MOLECULAR THERANOSTICS, LLC works in a range of technology areas.
How do I find firms similar to MOLECULAR THERANOSTICS, LLC?
Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.